Open-Source Genome Sequencing Startup Developing New Technology
Katie Cordrey — June 11, 2010 — Tech
References: masshightech & fiercebiotechresearch
John Boyce, founder of start-up GnuBio, says that the Harvard University spinout is in position to become an “eBay of Biomarkers.” GnuBio is developing open-source-genome-sequencing techniques that will make DNA testing faster and cheaper.
Open-source-genome-sequencing technology may mean that testing can be done in hours rather than days at a cost of about $30 instead of the several thousands now charged.
Implications - John Boyce has had a helping hand from Harvard professor Dave Weitz who specializes in physics and engineering, as well as Jessica Tonani who is the former associate director of product marketing at a sequencing company called Affymetrix Inc. The team says that this new open-source genome sequencing startup “promises to join together millions of biologicial samples that are currently siloed at institutes around the world.”
Open-source-genome-sequencing technology may mean that testing can be done in hours rather than days at a cost of about $30 instead of the several thousands now charged.
Implications - John Boyce has had a helping hand from Harvard professor Dave Weitz who specializes in physics and engineering, as well as Jessica Tonani who is the former associate director of product marketing at a sequencing company called Affymetrix Inc. The team says that this new open-source genome sequencing startup “promises to join together millions of biologicial samples that are currently siloed at institutes around the world.”
Trend Themes
-
Open-source Genome Sequencing — GnuBio's open-source-genome-sequencing techniques have the potential to disrupt the traditional DNA testing industry by making it faster and cheaper.
-
Rapid DNA Testing — GnuBio's open-source-genome-sequencing technology is expected to reduce the time needed for DNA testing from days to hours, creating a new market for instant DNA testing solutions.
-
Affordable DNA Testing — GnuBio's open-source-genome-sequencing technology promises to lower the cost of DNA testing to around $30, making it accessible and affordable for more people.
Industry Implications
-
Biotechnology — Open-source-genome-sequencing technology has the potential to transform the biotechnology industry by enabling faster and cheaper DNA testing.
-
Healthcare — GnuBio's open-source-genome-sequencing technology could create disruptive innovation opportunities in the healthcare industry by enabling rapid and affordable DNA testing for medical diagnosis and treatment.
-
Research — GnuBio's open-source-genome-sequencing startup has the potential to revolutionize genomics research by making it easier and cheaper to access and analyze DNA samples from around the world.
1
Score
Popularity
Activity
Freshness
